Yahoo Web Search

  1. About 28 search results

  1. CoV-GLUE: enabled by data from . CoV-GLUE maintains a database of mutations, insertions and deletions which have been observed in GISAID hCoV-19 sequences sampled from ongoing COVID-19 pandemic

  2. Apr 04, 2020 · National Center for Biotechnology Information

  3. Apr 16, 2020 · SARS-CoV-2 Substances Aerosols Grant support D18AC00031/Defense Advanced Research Projects Agency/International DEB-1557022/US/United States/United States ...

  4. Coronavirus COVID-19. Información, recomendaciones y medidas de prevención del Ministerio de Salud de la Nación..

  5. Oct 06, 2020 · SARS-CoV-2 replication and potential therapeutic targets. Potential antivirals target the different steps of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication, ranging from receptor binding, entry and fusion to replication. Furthermore, immunoglobulin-based and immunomodulatory drugs are potential therapeutics as well.

  6. May 12, 2022 · As the emerging variants of SARS-CoV-2 continue to drive the worldwide pandemic, there is a constant demand for vaccines that offer more effective and broad-spectrum protection. Here, we report a circular RNA (circRNA) vaccine that elicited potent neutralizing antibodies and T cell responses by expr …

  7. Apr 16, 2020 · The emergence of SARS-CoV-2 has resulted in >90,000 infections and >3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2 S and SAR …

  1. People also search for